ClinicalTrials.Veeva

Menu

Transcriptomic Profiling in Severely Injured Patients

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Inflammation
Trauma
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT02508272
Stv26/2007

Details and patient eligibility

About

Discovery of differences in the host response in patients with systemic inflammation and sepsis, and identification of novel, specific markers by using a longitudinal clinico-transcriptomic approach.

Full description

The aim of this study is to link defined clinical phenotypes with data on RNA obtained from blood samples by high throughput technologies. Genetic and molecular characteristics of the immune system after severe trauma will be crosslinked to clinical aspects of posttraumatic organ failure, with the goal of identifying typical molecular "fingerprints". Patients with and without sepsis or organ failure will be compared with the goal to develop a diagnostic test designed to predict the clinical course following severe trauma. Criteria for study enrollment includes patient age ≥18 y, an Injury Severity Score (ISS) ≥ 17 points, and time from injury to admission < 6 h. Whole blood from trauma patients will be collected within the first 6 h after trauma (day 0) and on days 1, 2, 3, 5, 7, 10, 14, and 21.

Enrollment

115 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient age ≥18 y
  • Injury Severity Score (ISS) ≥ 17 points
  • time from injury to admission < 6 h.

Exclusion criteria

Moribund Patients with:

  • PH < 7,1 or
  • Lactate > 15 mmol/l or
  • Base deficit > 15 mEq/l

Trial design

115 participants in 1 patient group

Trauma patients
Description:
age ≥18 y ISS ≥ 17 points admission \< 6 h.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems